VeriSIM Life is providing pharmaceutical scientists a competitive advantage to accelerate R&D decisions to bring more personalized drugs in the market. It is VeriSIM Life's mission to increase human life expectancy through intelligence driven biosystem simulations to truly personalize patient treatment. Fueling the acceleration of research and development in drug discovery, we create the tools needed for unprecedented medical breakthroughs to take place much earlier in the drug discovery and development timeline. It's our intention to create innovative products in the medical industry that will increase the efficiency and effectiveness of healthcare worldwide.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 08/14/19 | $5,200,000 |
Deepwater Asset Management Intel Capital  OCA Venture Partners Serra Ventures Stage Venture Partners Susa Ventures Village Global | undisclosed | |
| 01/06/22 | $15,000,000 | Series A |
Colorcon Ventures Debiopharm Intel Capital Morpheus Ventures OCA Ventures Serra Ventures Susa Ventures | undisclosed |
